DreaMed
AI solutions and personalized support for optimized insulin therapy, turning real-time patient data into actionable treatment. #t1d #t2d #diabetes.
Launch date
Employees
Market cap
-
Enterprise valuation
$12—18m (Dealroom.co estimates Aug 2024.)
Petah Tikva Center District (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$2.0m | Seed | ||
* | $3.3m | Early VC | |
$1.3m | Seed | ||
$5.0m | Grant | ||
* | $3.0m | Early VC | |
| Total Funding | $14.6m | ||
Recent News about DreaMed
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.